Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
EGFR mutation
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1956
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
EGFR L858R (90)
EGFR T790M (64)
EGFR exon 20 insertion (50)
EGFR wild-type (41)
EGFR L861Q (23)
EGFR C797S (22)
EGFR exon 21 mutation (20)
EGFR L858R + EGFR T790M (16)
EGFR exon 19 mutation (14)
EGFR A763_Y764insFQEA (13)
EGFR G719X (13)
EGFR S768I (12)
EGFR mutation + TP53 mutation (11)
EGFR C797S + EGFR T790M + EGFR L858R (9)
EGFR C797S + EGFR T790M + EGFR exon 19 deletion (9)
EGFR E746_A750del (8)
EGFR exon 20 mutation (8)
EGFRvIII mutation (8)
EGFR G719A (7)
EGFR G719S (7)
EGFR L747P (7)
EGFR exon 18 mutation (7)
EGFR T790M + EGFR C797S (6)
EGFR exon 19 deletion + EGFR L861Q (6)
EGFR mutation + BRAF V600E (6)
EGFR wild-type + ALK wild-type (6)
EGFR G719X + EGFR S768I (5)
EGFR K745_E746insIPVAIK (5)
EGFR G719C (4)
EGFR L861Q + EGFR G719X (4)
EGFR S492R (4)
EGFR mutation + KRAS mutation (4)
EGFR mutation + PIK3CA mutation (4)
EGFR D770 delinsGY (3)
EGFR D770_N771insSVD (3)
EGFR E709K (3)
EGFR E709_T710delinsD (3)
EGFR E746_S752delinsV (3)
EGFR G724S (3)
EGFR H773_V774insH (3)
EGFR L718Q (3)
EGFR L833V + EGFR H835L (3)
EGFR L858R + EGFR M766Q (3)
EGFR R521K (3)
EGFR T790M negative (3)
EGFR T854A (3)
EGFR exon 18-25 duplication (3)
EGFR exon 19 deletion + EGFR C797S (3)
EGFR exon 19 deletion + EGFR T790M + EGFR C797S (3)
EGFR mutation + CREBBP mutation (3)
HER-2 V777L + EGFR L858R (3)
EGFR A767_V769dup (2)
EGFR D761Y (2)
EGFR D770_N771insGT (2)
EGFR E114K (2)
EGFR G465R (2)
EGFR G63R (2)
EGFR G719A + EGFR G779C (2)
EGFR G719C + EGFR S768I (2)
EGFR G719S + EGFR L861Q (2)
EGFR G874S (2)
EGFR H1975 (2)
EGFR K708R (2)
EGFR L747-S752 del (2)
EGFR L747_A750delinsP (2)
EGFR L833F + EGFR L861Q (2)
EGFR L858R + EGFR A871G (2)
EGFR L858R + EGFR L718Q (2)
EGFR L858R + RBM10 Y36* (2)
EGFR L858R + TP53 mutation (2)
EGFR L860R (2)
EGFR L861R (2)
EGFR N771delinsKG (2)
EGFR P596L (2)
EGFR R165Q (2)
EGFR R222C (2)
EGFR S645C + EGFR L858R (2)
EGFR T790M + KRAS mutation (2)
EGFR T790M + PIK3CA H1047R (2)
EGFR V802I + KRAS mutation (2)
EGFR exon 19 duplication (2)
EGFR exon 19 insertion (2)
EGFR exon 20 insertion + EGFR T790M (2)
EGFR mutation + ATM mutation (2)
EGFR mutation + BRAF V600 (2)
EGFR mutation + CDKN2A mutation (2)
EGFR mutation + EGFR T790M (2)
EGFR mutation + MET mutation (2)
EGFR mutation + NRAS Q61K (2)
EGFR mutation + PTEN mutation (2)
EGFR mutation + TP53 mutation + ARID1A mutation (2)
EGFR mutation + TP53 mutation + BRCA1 mutation (2)
EGFR mutation + TP53 mutation + NF1 mutation (2)
EGFR mutation + TP53 mutation + PTEN mutation (2)
EGFR mutation + TP53 mutation + RB1 mutation (2)
EGFR T790L (2)
EGFR delE709_T710insD (2)
KRAS mutation + EGFR wild-type (2)
MET exon 14 mutation + EGFR exon 20 insertion (2)
ALK L1152R + EGFR mutation (1)
ALK rearrangement + ALK T1151M + ALK L1198F + EGFR A839V (1)
ALK rearrangement + EGFR D761N + KRAS V14I (1)
ALK rearrangement + TP53 R175H + EGFR A839V + PI3KCA mutation (1)
BRAF mutation + EGFR mutation (1)
CDK4 mutation + EGFR mutation (1)
DDR + EGFR mutation (1)
EGFR 181946 C>T (1)
EGFR A289V (1)
EGFR A750P (1)
EGFR A763V (1)
EGFR A767_V769dupASV (1)
EGFR A767dupASV (1)
EGFR A859T (1)
EGFR C796S (1)
EGFR C796S + EGFR V802I (1)
EGFR C797S + EGFR C796S (1)
EGFR C797S + EGFR exon 20 insertion (1)
EGFR D770_N771insGL (1)
EGFR D770_N771insGT + EGFR V774_C775insHV (1)
EGFR E690K (1)
EGFR E709A + EGFR G719C (1)
EGFR E709G (1)
EGFR E709Q (1)
EGFR E746 (1)
EGFR E746G (1)
EGFR E746_T751delinsl (1)
EGFR E758D (1)
EGFR E884K (1)
EGFR G2607A (1)
EGFR G709T (1)
EGFR G719A + EGFR I706T (1)
EGFR G719A + EGFR L833V (1)
EGFR G719A + EGFR R776C (1)
EGFR G719A + EGFR S768I (1)
EGFR G719A + EGFR T790M (1)
EGFR G719C + EGFR E709V (1)
EGFR G719D (1)
EGFR G719S + EGFR S768I (1)
EGFR G719X + EGFR E709F (1)
EGFR G719X + EGFR L861Q + EGFR S768I (1)
EGFR G719X + TP53 mutation (1)
EGFR G724S + EGFR R776H (1)
EGFR G735R (1)
EGFR G796S (1)
EGFR G836S (1)
EGFR H773L + EGFR V774M (1)
EGFR H773_V774insNPH (1)
EGFR H773delinsNPY (1)
EGFR H773delinsYNPY (1)
EGFR H835L (1)
EGFR I744_K745insKIPVAI (1)
EGFR K467T (1)
EGFR K757R (1)
EGFR L718V + TP53 V727M + EGFR L858R (1)
EGFR L746_T70delinsS (1)
EGFR L746_T750del (1)
EGFR L747S (1)
EGFR L747_A750>P (1)
EGFR L747_P753delinsS (1)
EGFR L747_T751delinsP (1)
EGFR L747_T751delinsS (1)
EGFR L747_T753delinsS (1)
EGFR L833V (1)
EGFR L8585R + EGFR T790M + RBM10 G840fs*7 (1)
EGFR L858R + ALK R1275Q (1)
EGFR L858R + ALK rearrangement (1)
EGFR L858R + EGFR C797S (1)
EGFR L858R + EGFR D761Y (1)
EGFR L858R + EGFR E709G (1)
EGFR L858R + EGFR E709X (1)
EGFR L858R + EGFR E709X + CTNNB1 mutation (1)
EGFR L858R + EGFR E884K (1)
EGFR L858R + EGFR L747V (1)
EGFR L858R + EGFR R776H (1)
EGFR L858R + EGFR S765I (1)
EGFR L858R + EGFR S768I (1)
EGFR L858R + EGFR T854A (1)
EGFR L858R + EGFR V843I (1)
EGFR L858R + EGFR exon 21 deletion (1)
EGFR L858R + FGF3 mutation (1)
EGFR L858R + IDH1 R132C (1)
EGFR L858R + PIK3CA H1047R + PIK3CA E545K (1)
EGFR L858R + RBM10 2167-1 G>T (1)
EGFR L858R + RBM10 Q255* (1)
EGFR L858R + RBM10 Q595* (1)
EGFR L858R + TP53 R273C + HER-2 S442L (1)
EGFR L858R + TP53 wild-type (1)
EGFR L861P (1)
EGFR L861Q + EGFR exon 20 insertion (1)
EGFR L861Q + TP53 mutation (1)
EGFR L861Q + TP53 mutation + RB1 mutation (1)
EGFR L861X (1)
EGFR M277E (1)
EGFR M766Q (1)
EGFR M766_A767insASV (1)
EGFR N771_P772insH (1)
EGFR N771_P772insVal (1)
EGFR P546S (1)
EGFR P753S (1)
EGFR P772_H773insYNP (1)
EGFR P772_H773insYNP + EGFR H773Y (1)
EGFR P772_V774insPHV (1)
EGFR Q787Q (1)
EGFR R1052K (1)
EGFR R451C (1)
EGFR R776C + EGFR L861Q (1)
EGFR R776H (1)
EGFR R776H + EGFR C797S (1)
EGFR R776H + EGFR L861Q (1)
EGFR S464L (1)
EGFR S720I (1)
EGFR S752_I759del (1)
EGFR S768I + TP53 mutation (1)
EGFR S768_D770dup (1)
EGFR S768_D770dupSVD (1)
EGFR S768dupSVD (1)
EGFR S784F (1)
EGFR T263P (1)
EGFR T751_I759>S (1)
EGFR T790I (1)
EGFR T790M + BRAF V600E (1)
EGFR T790M + EGFR L792F (1)
EGFR T790M + EGFR L833V + EGFR H835L (1)
EGFR T790M + EGFR L861Q (1)
EGFR T790M + EGFR S768I + EGFR L858R (1)
EGFR T790M + HER-2 mutation (1)
EGFR T790M + KRAS G12V (1)
EGFR T790M + MET mutation (1)
EGFR T790M + PARP1 mutation (1)
EGFR T790M + PIK3CA Mutation (1)
EGFR T790M + TP53 R237C (1)
EGFR T854A + EGFR T790M (1)
EGFR T858R (1)
EGFR V769A (1)
EGFR V769_770insASV (1)
EGFR V774_C775insHV (1)
EGFR V786M (1)
EGFR V802I (1)
EGFR V834L (1)
EGFR Y764_V765insHH (1)
EGFR exon 18 mutation + EGFR exon 21 mutation (1)
EGFR exon 19 deletion + ALK mutation (1)
EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)
EGFR exon 19 deletion + BRAF V600E (1)
EGFR exon 19 deletion + BRCA2 mutation (1)
EGFR exon 19 deletion + EGFR G724S + EGFR T790M (1)
EGFR exon 19 deletion + EGFR T790L (1)
EGFR exon 19 deletion + TP53 exon 8 mutation (1)
EGFR exon 19 deletion + TP53 mutation (1)
EGFR exon 19 mutation + EGFR C797S + PIK3CA mutation (1)
EGFR exon 20 insertion + EGFR G719X + EGFR L858R (1)
EGFR exon 20 insertion + NRAS G13V + NF1 R69fs + NF1 S340fs (1)
EGFR exon 20 insertion + TP53 G244A + SPTA1 mutation (1)
EGFR exon 20 mutation + EGFR V774M + EGFR S768I (1)
EGFR exon 21 deletion + EGFR L858R + MET Exon 14 mutation (1)
EGFR exon 21 mutation + EGFR L858R (1)
EGFR mutation + ALK mutation (1)
EGFR mutation + BRAF G469A (1)
EGFR mutation + BRAF mutation + TP53 mutation (1)
EGFR mutation + CTBP2 rs376695472 (1)
EGFR mutation + CTBP2 rs945665113 (1)
EGFR mutation + EGFR T790M + EGFR C797S (1)
EGFR mutation + FAT3 mutation (1)
EGFR mutation + GRM8 mutation (1)
EGFR mutation + HLA-DRB5 rs1071748 (1)
EGFR mutation + HLA-DRB5 rs184278615 (1)
EGFR mutation + HLA-DRB5 rs20146916 (1)
EGFR mutation + IDH1 mutation (1)
EGFR mutation + KIR3DL1 rs199822561 (1)
EGFR mutation + KIR3DL1 rs200821495 (1)
EGFR mutation + KIR3DL1 rs72629105 (1)
EGFR mutation + KIR3DL2 rs973541788 (1)
EGFR mutation + LRP1B mutation (1)
EGFR mutation + MDM4 *32C>A (1)
EGFR mutation + MET Y1003N (1)
EGFR mutation + NOTCH1 mutation (1)
EGFR mutation + RB1 mutation (1)
EGFR mutation + SMAD4 mutation (1)
EGFR mutation + TP53 exon 6 mutation (1)
EGFR mutation + TP53 exon 7 mutation (1)
EGFR mutation + UBXN11 mutation (1)
EGFR mutation + ZNF217 mutation (1)
EGFR mutation+ IDH1 R132H (1)
EGFR rearrangement (1)
EGFR wild-type + ALK wild-type + ROS1 wild-type (1)
EGFR wild-type + ALK wild-type + STK11 mutation (1)
EGFR wild-type + MET wild-type (1)
EGFR-SEPTIN14 rearrangement (1)
EGFR G729A + EGFR L858R (1)
EGFR T790M + TP53 mutation (1)
IDH1 R132C + EGFR L861Q (1)
IDH2 R140W + EGFR L858R (1)
KRAS codon 12 mutation + KRAS codon 13 mutation + EGFR mutation (1)
MTOR L1433S + EGFR L858R + EGFR T790M (1)
EGFR A839V (0)
EGFR E709A (0)
EGFR E709F (0)
EGFR G779C (0)
EGFR G873E (0)
EGFR H773L (0)
EGFR K754E (0)
EGFR L747_S752del (0)
EGFR L747_T750del (0)
EGFR L858R + EGFR G779S (0)
EGFR L858R + RBM10 Q255 (0)
EGFR R776C (0)
EGFR S765I (0)
EGFR T785A + EGFR L861Q + EGFR H297_E298 (0)
EGFR V774M (0)
EGFR mutation + APC mutation (0)
EGFR rs4947492 (0)
MET exon 14 skipping mutation + EGFR G709T (0)
EGFR L858R (90)
EGFR T790M (64)
EGFR exon 20 insertion (50)
EGFR wild-type (41)
EGFR L861Q (23)
EGFR C797S (22)
EGFR exon 21 mutation (20)
EGFR L858R + EGFR T790M (16)
EGFR exon 19 mutation (14)
EGFR A763_Y764insFQEA (13)
EGFR G719X (13)
EGFR S768I (12)
EGFR mutation + TP53 mutation (11)
EGFR C797S + EGFR T790M + EGFR L858R (9)
EGFR C797S + EGFR T790M + EGFR exon 19 deletion (9)
EGFR E746_A750del (8)
EGFR exon 20 mutation (8)
EGFRvIII mutation (8)
EGFR G719A (7)
EGFR G719S (7)
EGFR L747P (7)
EGFR exon 18 mutation (7)
EGFR T790M + EGFR C797S (6)
EGFR exon 19 deletion + EGFR L861Q (6)
EGFR mutation + BRAF V600E (6)
EGFR wild-type + ALK wild-type (6)
EGFR G719X + EGFR S768I (5)
EGFR K745_E746insIPVAIK (5)
EGFR G719C (4)
EGFR L861Q + EGFR G719X (4)
EGFR S492R (4)
EGFR mutation + KRAS mutation (4)
EGFR mutation + PIK3CA mutation (4)
EGFR D770 delinsGY (3)
EGFR D770_N771insSVD (3)
EGFR E709K (3)
EGFR E709_T710delinsD (3)
EGFR E746_S752delinsV (3)
EGFR G724S (3)
EGFR H773_V774insH (3)
EGFR L718Q (3)
EGFR L833V + EGFR H835L (3)
EGFR L858R + EGFR M766Q (3)
EGFR R521K (3)
EGFR T790M negative (3)
EGFR T854A (3)
EGFR exon 18-25 duplication (3)
EGFR exon 19 deletion + EGFR C797S (3)
EGFR exon 19 deletion + EGFR T790M + EGFR C797S (3)
EGFR mutation + CREBBP mutation (3)
HER-2 V777L + EGFR L858R (3)
EGFR A767_V769dup (2)
EGFR D761Y (2)
EGFR D770_N771insGT (2)
EGFR E114K (2)
EGFR G465R (2)
EGFR G63R (2)
EGFR G719A + EGFR G779C (2)
EGFR G719C + EGFR S768I (2)
EGFR G719S + EGFR L861Q (2)
EGFR G874S (2)
EGFR H1975 (2)
EGFR K708R (2)
EGFR L747-S752 del (2)
EGFR L747_A750delinsP (2)
EGFR L833F + EGFR L861Q (2)
EGFR L858R + EGFR A871G (2)
EGFR L858R + EGFR L718Q (2)
EGFR L858R + RBM10 Y36* (2)
EGFR L858R + TP53 mutation (2)
EGFR L860R (2)
EGFR L861R (2)
EGFR N771delinsKG (2)
EGFR P596L (2)
EGFR R165Q (2)
EGFR R222C (2)
EGFR S645C + EGFR L858R (2)
EGFR T790M + KRAS mutation (2)
EGFR T790M + PIK3CA H1047R (2)
EGFR V802I + KRAS mutation (2)
EGFR exon 19 duplication (2)
EGFR exon 19 insertion (2)
EGFR exon 20 insertion + EGFR T790M (2)
EGFR mutation + ATM mutation (2)
EGFR mutation + BRAF V600 (2)
EGFR mutation + CDKN2A mutation (2)
EGFR mutation + EGFR T790M (2)
EGFR mutation + MET mutation (2)
EGFR mutation + NRAS Q61K (2)
EGFR mutation + PTEN mutation (2)
EGFR mutation + TP53 mutation + ARID1A mutation (2)
EGFR mutation + TP53 mutation + BRCA1 mutation (2)
EGFR mutation + TP53 mutation + NF1 mutation (2)
EGFR mutation + TP53 mutation + PTEN mutation (2)
EGFR mutation + TP53 mutation + RB1 mutation (2)
EGFR T790L (2)
EGFR delE709_T710insD (2)
KRAS mutation + EGFR wild-type (2)
MET exon 14 mutation + EGFR exon 20 insertion (2)
ALK L1152R + EGFR mutation (1)
ALK rearrangement + ALK T1151M + ALK L1198F + EGFR A839V (1)
ALK rearrangement + EGFR D761N + KRAS V14I (1)
ALK rearrangement + TP53 R175H + EGFR A839V + PI3KCA mutation (1)
BRAF mutation + EGFR mutation (1)
CDK4 mutation + EGFR mutation (1)
DDR + EGFR mutation (1)
EGFR 181946 C>T (1)
EGFR A289V (1)
EGFR A750P (1)
EGFR A763V (1)
EGFR A767_V769dupASV (1)
EGFR A767dupASV (1)
EGFR A859T (1)
EGFR C796S (1)
EGFR C796S + EGFR V802I (1)
EGFR C797S + EGFR C796S (1)
EGFR C797S + EGFR exon 20 insertion (1)
EGFR D770_N771insGL (1)
EGFR D770_N771insGT + EGFR V774_C775insHV (1)
EGFR E690K (1)
EGFR E709A + EGFR G719C (1)
EGFR E709G (1)
EGFR E709Q (1)
EGFR E746 (1)
EGFR E746G (1)
EGFR E746_T751delinsl (1)
EGFR E758D (1)
EGFR E884K (1)
EGFR G2607A (1)
EGFR G709T (1)
EGFR G719A + EGFR I706T (1)
EGFR G719A + EGFR L833V (1)
EGFR G719A + EGFR R776C (1)
EGFR G719A + EGFR S768I (1)
EGFR G719A + EGFR T790M (1)
EGFR G719C + EGFR E709V (1)
EGFR G719D (1)
EGFR G719S + EGFR S768I (1)
EGFR G719X + EGFR E709F (1)
EGFR G719X + EGFR L861Q + EGFR S768I (1)
EGFR G719X + TP53 mutation (1)
EGFR G724S + EGFR R776H (1)
EGFR G735R (1)
EGFR G796S (1)
EGFR G836S (1)
EGFR H773L + EGFR V774M (1)
EGFR H773_V774insNPH (1)
EGFR H773delinsNPY (1)
EGFR H773delinsYNPY (1)
EGFR H835L (1)
EGFR I744_K745insKIPVAI (1)
EGFR K467T (1)
EGFR K757R (1)
EGFR L718V + TP53 V727M + EGFR L858R (1)
EGFR L746_T70delinsS (1)
EGFR L746_T750del (1)
EGFR L747S (1)
EGFR L747_A750>P (1)
EGFR L747_P753delinsS (1)
EGFR L747_T751delinsP (1)
EGFR L747_T751delinsS (1)
EGFR L747_T753delinsS (1)
EGFR L833V (1)
EGFR L8585R + EGFR T790M + RBM10 G840fs*7 (1)
EGFR L858R + ALK R1275Q (1)
EGFR L858R + ALK rearrangement (1)
EGFR L858R + EGFR C797S (1)
EGFR L858R + EGFR D761Y (1)
EGFR L858R + EGFR E709G (1)
EGFR L858R + EGFR E709X (1)
EGFR L858R + EGFR E709X + CTNNB1 mutation (1)
EGFR L858R + EGFR E884K (1)
EGFR L858R + EGFR L747V (1)
EGFR L858R + EGFR R776H (1)
EGFR L858R + EGFR S765I (1)
EGFR L858R + EGFR S768I (1)
EGFR L858R + EGFR T854A (1)
EGFR L858R + EGFR V843I (1)
EGFR L858R + EGFR exon 21 deletion (1)
EGFR L858R + FGF3 mutation (1)
EGFR L858R + IDH1 R132C (1)
EGFR L858R + PIK3CA H1047R + PIK3CA E545K (1)
EGFR L858R + RBM10 2167-1 G>T (1)
EGFR L858R + RBM10 Q255* (1)
EGFR L858R + RBM10 Q595* (1)
EGFR L858R + TP53 R273C + HER-2 S442L (1)
EGFR L858R + TP53 wild-type (1)
EGFR L861P (1)
EGFR L861Q + EGFR exon 20 insertion (1)
EGFR L861Q + TP53 mutation (1)
EGFR L861Q + TP53 mutation + RB1 mutation (1)
EGFR L861X (1)
EGFR M277E (1)
EGFR M766Q (1)
EGFR M766_A767insASV (1)
EGFR N771_P772insH (1)
EGFR N771_P772insVal (1)
EGFR P546S (1)
EGFR P753S (1)
EGFR P772_H773insYNP (1)
EGFR P772_H773insYNP + EGFR H773Y (1)
EGFR P772_V774insPHV (1)
EGFR Q787Q (1)
EGFR R1052K (1)
EGFR R451C (1)
EGFR R776C + EGFR L861Q (1)
EGFR R776H (1)
EGFR R776H + EGFR C797S (1)
EGFR R776H + EGFR L861Q (1)
EGFR S464L (1)
EGFR S720I (1)
EGFR S752_I759del (1)
EGFR S768I + TP53 mutation (1)
EGFR S768_D770dup (1)
EGFR S768_D770dupSVD (1)
EGFR S768dupSVD (1)
EGFR S784F (1)
EGFR T263P (1)
EGFR T751_I759>S (1)
EGFR T790I (1)
EGFR T790M + BRAF V600E (1)
EGFR T790M + EGFR L792F (1)
EGFR T790M + EGFR L833V + EGFR H835L (1)
EGFR T790M + EGFR L861Q (1)
EGFR T790M + EGFR S768I + EGFR L858R (1)
EGFR T790M + HER-2 mutation (1)
EGFR T790M + KRAS G12V (1)
EGFR T790M + MET mutation (1)
EGFR T790M + PARP1 mutation (1)
EGFR T790M + PIK3CA Mutation (1)
EGFR T790M + TP53 R237C (1)
EGFR T854A + EGFR T790M (1)
EGFR T858R (1)
EGFR V769A (1)
EGFR V769_770insASV (1)
EGFR V774_C775insHV (1)
EGFR V786M (1)
EGFR V802I (1)
EGFR V834L (1)
EGFR Y764_V765insHH (1)
EGFR exon 18 mutation + EGFR exon 21 mutation (1)
EGFR exon 19 deletion + ALK mutation (1)
EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)
EGFR exon 19 deletion + BRAF V600E (1)
EGFR exon 19 deletion + BRCA2 mutation (1)
EGFR exon 19 deletion + EGFR G724S + EGFR T790M (1)
EGFR exon 19 deletion + EGFR T790L (1)
EGFR exon 19 deletion + TP53 exon 8 mutation (1)
EGFR exon 19 deletion + TP53 mutation (1)
EGFR exon 19 mutation + EGFR C797S + PIK3CA mutation (1)
EGFR exon 20 insertion + EGFR G719X + EGFR L858R (1)
EGFR exon 20 insertion + NRAS G13V + NF1 R69fs + NF1 S340fs (1)
EGFR exon 20 insertion + TP53 G244A + SPTA1 mutation (1)
EGFR exon 20 mutation + EGFR V774M + EGFR S768I (1)
EGFR exon 21 deletion + EGFR L858R + MET Exon 14 mutation (1)
EGFR exon 21 mutation + EGFR L858R (1)
EGFR mutation + ALK mutation (1)
EGFR mutation + BRAF G469A (1)
EGFR mutation + BRAF mutation + TP53 mutation (1)
EGFR mutation + CTBP2 rs376695472 (1)
EGFR mutation + CTBP2 rs945665113 (1)
EGFR mutation + EGFR T790M + EGFR C797S (1)
EGFR mutation + FAT3 mutation (1)
EGFR mutation + GRM8 mutation (1)
EGFR mutation + HLA-DRB5 rs1071748 (1)
EGFR mutation + HLA-DRB5 rs184278615 (1)
EGFR mutation + HLA-DRB5 rs20146916 (1)
EGFR mutation + IDH1 mutation (1)
EGFR mutation + KIR3DL1 rs199822561 (1)
EGFR mutation + KIR3DL1 rs200821495 (1)
EGFR mutation + KIR3DL1 rs72629105 (1)
EGFR mutation + KIR3DL2 rs973541788 (1)
EGFR mutation + LRP1B mutation (1)
EGFR mutation + MDM4 *32C>A (1)
EGFR mutation + MET Y1003N (1)
EGFR mutation + NOTCH1 mutation (1)
EGFR mutation + RB1 mutation (1)
EGFR mutation + SMAD4 mutation (1)
EGFR mutation + TP53 exon 6 mutation (1)
EGFR mutation + TP53 exon 7 mutation (1)
EGFR mutation + UBXN11 mutation (1)
EGFR mutation + ZNF217 mutation (1)
EGFR mutation+ IDH1 R132H (1)
EGFR rearrangement (1)
EGFR wild-type + ALK wild-type + ROS1 wild-type (1)
EGFR wild-type + ALK wild-type + STK11 mutation (1)
EGFR wild-type + MET wild-type (1)
EGFR-SEPTIN14 rearrangement (1)
EGFR G729A + EGFR L858R (1)
EGFR T790M + TP53 mutation (1)
IDH1 R132C + EGFR L861Q (1)
IDH2 R140W + EGFR L858R (1)
KRAS codon 12 mutation + KRAS codon 13 mutation + EGFR mutation (1)
MTOR L1433S + EGFR L858R + EGFR T790M (1)
EGFR A839V (0)
EGFR E709A (0)
EGFR E709F (0)
EGFR G779C (0)
EGFR G873E (0)
EGFR H773L (0)
EGFR K754E (0)
EGFR L747_S752del (0)
EGFR L747_T750del (0)
EGFR L858R + EGFR G779S (0)
EGFR L858R + RBM10 Q255 (0)
EGFR R776C (0)
EGFR S765I (0)
EGFR T785A + EGFR L861Q + EGFR H297_E298 (0)
EGFR V774M (0)
EGFR mutation + APC mutation (0)
EGFR rs4947492 (0)
MET exon 14 skipping mutation + EGFR G709T (0)
›
Related tests:
Oncomine™ Dx Target Test (10)
Idylla™ EGFR Mutation Test
Lung Cancer 8-Gene Kit
Oncomine™ Dx Target Test (10)
Idylla™ EGFR Mutation Test
Lung Cancer 8-Gene Kit
Associations
(196)
News
Trials
Search handles
@ADesaiMD
@APassaroMD
@AdnanNagrial
@AnaVManana
@AncelJulienMD
@AndresFCardonaZ
@BenjaminBesseMD
@BiagioMd
@BijoyTelivala
@BoschBarrera
@BrendonStilesMD
@BrunaPellini
@CAudigierValett
@CarlesEscriu
@CharuAggarwalMD
@ChristianRolfo
@ClaudioVladmir
@DevikaDasMD
@DocMCotant
@DoctorJSpicer
@DrBivas
@DrChoueiri
@DrHealeyBird
@DrJNaidoo
@DrMarkAwad
@DrR_DUNNE
@DrSanjayPopat
@DrSteveMartin
@DrVijayPatil11
@DrViteri
@Dr_Ivanoncologo
@Dr_R_Kurzrock
@EladSharonMD
@FawziAbuRous
@FordePatrick
@GRecondoMD
@GautschiOliver
@Geeky_Foodie
@GlopesMd
@HHorinouchi
@HenningWillers
@IyengarPuneeth
@JackWestMD
@Jbauml
@JessicaJLinMD
@JordiRemon
@Joshua_Reuss
@JulienMazieres
@Kristel_GT
@Latinamd
@LeXiuning
@LeciaSequist
@LuisERaez1
@LuisLara_M
@LungCancerDr
@MLPOncoData
@MPishvaian
@MarieWislez
@MartinReck2
@Mat_Guc
@NormandBlais
@OncoLucus
@PamelaKunzMD
@PatelOncology
@PatrickCMa1
@RManochakian
@RenoHemonc
@RielyMD
@SKabrajiMD
@SalemGIOncDoc
@SantiCabezas1
@ShaalanBeg
@ShrutiPatelMD
@StephenVLiu
@SuyogCancer
@SyedMAhmedMDPhD
@TiansterZhang
@TommyJohn00
@Tony_Calles
@VamsiVelcheti
@VincentRK
@VivekSubbiah
@YasarHammor
@aakonc
@abraocantoMD
@aftimosp
@antonyruggeri
@bmassutis
@bpiperdi
@bpshah79
@cczielinski
@cdanicas
@christine_lovly
@chulkimMD
@cinthiavgauna
@collin_blakely
@diegoadiazg
@dipeshuprety4
@dplanchard
@dr_yakupergun
@drcbsteer
@drgandara
@drkpavithran
@esinghimd
@g_mountzios
@herbloong
@ipreeshagul
@jonathanloree
@jsoriamd
@lindamahj
@malkadav
@mlazqui
@mtmdphd
@n8pennell
@ns_chd
@oncologician
@pashtoonkasi
@ravikanesvaran
@rdoebele
@rsm2800
@ryangentzler
@saadvikdr
@smitha42
@tehfem
@theabzlab
@trnsltnl
@wangyub
@weldeiry
@weoncologists
@yekeduz_emre
Search handles
@ADesaiMD
@APassaroMD
@AdnanNagrial
@AnaVManana
@AncelJulienMD
@AndresFCardonaZ
@BenjaminBesseMD
@BiagioMd
@BijoyTelivala
@BoschBarrera
@BrendonStilesMD
@BrunaPellini
@CAudigierValett
@CarlesEscriu
@CharuAggarwalMD
@ChristianRolfo
@ClaudioVladmir
@DevikaDasMD
@DocMCotant
@DoctorJSpicer
@DrBivas
@DrChoueiri
@DrHealeyBird
@DrJNaidoo
@DrMarkAwad
@DrR_DUNNE
@DrSanjayPopat
@DrSteveMartin
@DrVijayPatil11
@DrViteri
@Dr_Ivanoncologo
@Dr_R_Kurzrock
@EladSharonMD
@FawziAbuRous
@FordePatrick
@GRecondoMD
@GautschiOliver
@Geeky_Foodie
@GlopesMd
@HHorinouchi
@HenningWillers
@IyengarPuneeth
@JackWestMD
@Jbauml
@JessicaJLinMD
@JordiRemon
@Joshua_Reuss
@JulienMazieres
@Kristel_GT
@Latinamd
@LeXiuning
@LeciaSequist
@LuisERaez1
@LuisLara_M
@LungCancerDr
@MLPOncoData
@MPishvaian
@MarieWislez
@MartinReck2
@Mat_Guc
@NormandBlais
@OncoLucus
@PamelaKunzMD
@PatelOncology
@PatrickCMa1
@RManochakian
@RenoHemonc
@RielyMD
@SKabrajiMD
@SalemGIOncDoc
@SantiCabezas1
@ShaalanBeg
@ShrutiPatelMD
@StephenVLiu
@SuyogCancer
@SyedMAhmedMDPhD
@TiansterZhang
@TommyJohn00
@Tony_Calles
@VamsiVelcheti
@VincentRK
@VivekSubbiah
@YasarHammor
@aakonc
@abraocantoMD
@aftimosp
@antonyruggeri
@bmassutis
@bpiperdi
@bpshah79
@cczielinski
@cdanicas
@christine_lovly
@chulkimMD
@cinthiavgauna
@collin_blakely
@diegoadiazg
@dipeshuprety4
@dplanchard
@dr_yakupergun
@drcbsteer
@drgandara
@drkpavithran
@esinghimd
@g_mountzios
@herbloong
@ipreeshagul
@jonathanloree
@jsoriamd
@lindamahj
@malkadav
@mlazqui
@mtmdphd
@n8pennell
@ns_chd
@oncologician
@pashtoonkasi
@ravikanesvaran
@rdoebele
@rsm2800
@ryangentzler
@saadvikdr
@smitha42
@tehfem
@theabzlab
@trnsltnl
@wangyub
@weldeiry
@weoncologists
@yekeduz_emre
Filter by
Latest
9ms
WATCH: Expert oncologists reflect on the state of molecular testing in NSCLC and how it informs the management of patients with uncommon EGFR mutations. @benlevylungdoc @hopkinskimmel @UMiamiHealth #lungcancer https://t.co/vp5pIxGdHx (@OncLive)
9 months ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
9ms
In #clinicaltrial EA5161, investigators at are testing a new treatment approach for patients with #NSCLC w/ EGFR ex20-ins mutations. For more: https://t.co/pwy12PyvBr cc: @ZPiotrowskaMD, @LeciaSequist (@eaonc)
9 months ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
9ms
#Clinicaltrial EA5162, led by @ZPiotrowskaMD and @LeciaSequist of @MGHCancerCenter, will evaluate how well osimertinib works in treating pts w/ advanced #NSCLC w/ EGFR ex20-ins mutations. Learn more here: https://t.co/pwy12PyvBr #lcsm (@eaonc)
9 months ago
Clinical • Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Tagrisso (osimertinib)
9ms
Delighted to share our latest paper on the mechanistic modeling of disease progression in EGFR-mutant lung adenocarcinoma: https://t.co/dsB0zfo9rc A special thanks to @MDuruisseaux & to all co-authors from @novadiscovery , @JanssenFRA. (@Claudio_MonT_s)
9 months ago
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
9ms
Join us for this fun + inspiring “thinktank” to study #EGFR-mutant #lungcancer with a great community! Meet the incredible @jillfeldman4 + @ivybelkins! Link for abstract submission below. Deadline 8/18. #hemeoncfellows @OncoAlert #LCSM @EGFRResisters @EGFRSummit https://t.co/SiobKVyQKA (@christine_lovly)
9 months ago
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
9ms
“Adjuvant Osimertinib Improves Overall Survival in EGFR-Mutated Lung Cancer” presented by Dr Roy S. Herbst and colleagues at the 2023 ASCO Annual Meeting https://t.co/gK0miTQZc6 @DrRoyHerbstYale @ASCO #ASCO23 (@clinadvances)
9 months ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Tagrisso (osimertinib)
9ms
A multiD intervention (radiology, pathology, pharmacy, & oncology) ⬇️⬇️ time to start osimertinib for pts with #EGFR-mutant #NSCLC (5 vs 23 days) by directly analyzing frozen tissue & engaging pharmacy early: https://t.co/FHkNGChqVK #LungCancer #lcsm @IbiayiMD (@JCOOP_ASCO)
9 months ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Tagrisso (osimertinib)
9ms
#Clinicaltrial EA5162, led by @ZPiotrowskaMD and @LeciaSequist of @MGHCancerCenter, will evaluate how well osimertinib works in treating pts w/ advanced #NSCLC w/ EGFR ex20-ins mutations. Learn more here: https://t.co/pwy12PyvBr #lcsm (@eaonc)
9 months ago
Clinical • Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Tagrisso (osimertinib)
9ms
Honored to write an invited editorial on "Zipalertinib in EGFR Exon 20–Mutant NSCLC" - out now in @JCO_ASCO @ASCO @StephenVLiu - we discuss the role of novel TKIs, and drug development in this rare, but increasingly crowded space! Congrats to the authors on this important… https://t.co/q2gu83PHLN (@CharuAggarwalMD)
9 months ago
EGFR exon 20
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR exon 20 insertion • EGFR exon 20 mutation
|
zipalertinib (CLN-081)
9ms
A targeted therapy drug improved survival in pts w/ #lungcancer who have #EGFR mutations. PC3I's @CharuAggarwalMD provided input for @theNCI: “This confirms our practice to test for EGFR mutations and recommend adjuvant targeted therapy with osimertinib” https://t.co/O3AdUxmIdX (@PC3Innovation)
9 months ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Tagrisso (osimertinib)
10ms
Also, I don’t think supportive care docs necessarily know the scope of therapeutic options or outcomes and they are sometimes “brought in” to get pts into hospice. PS3 with stage IV pancreatic cancer is very different than PS3 with untreated EGFR mutant lung cancer. (@Alexmenter)
10 months ago
Clinical • Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
10ms
Yeah I think oncology gets very nuanced and we don’t expect internists to know this stuff. For example metastatic breast cancer sounds terrible. But with hormonal therapies patients can often live many years with good QOL. Same with EGFR mutated metastatic NSCLC (@INizMD)
10 months ago
Clinical • Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
10ms
Brilliant overview from biology to trials from @RamalingamMD @WinshipAtEmory on EGFR mutant refractory #lungcancer — great objectives to improve IO therapies for NSCLC in their SPORE program. #Pitt23 @UPMC @UPMCHillmanCC (@TiansterZhang)
10 months ago
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
10ms
Dr. @ipreeshagul presenting EGFR Mutations in Advanced #NSCLC. #TargetedTherapiesInLungCancer #LungCancer #CancerEducation #cancerGRACE (@cancerGRACE)
10 months ago
Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
10ms
Dr. @ipreeshagul is a dynamic ⭐️ speaker - a comprehensive, to-the-point review of current treatment landscape in EGFR-mutated NSCLC including the latest ASCO updates, at Targeted Therapies Forum 2023 @cancergrace (@JessicaJLinMD)
10 months ago
Review
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
10ms
@teekayowo gives a poignant introduction and gift for @RamalingamMD @WinshipAtEmory, “who we want to be when we grow up” — giving keynote talk on treatment in refractory EGFR mutant lung cancer #Pitt23 @UPMC @UPMCHillmanCC (@TiansterZhang)
10 months ago
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
10ms
MET positivity showed predictive value for durable responses with amivantamab plus lazertinib in patients with EGFR-mutated NSCLC whose disease progressed on/after osimertinib and are chemotherapy naïve. @BenjaminBesseMD @GustaveRoussy @ASCO #ASCO23 #lcsm https://t.co/UHG7PDlrer (@OncLive)
10 months ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Tagrisso (osimertinib) • Rybrevant (amivantamab-vmjw) • Leclaza (lazertinib)
10ms
Latest living guideline update on stage IV NSCLC just published. Listen to Dr. @ns_chd share the new updates - including second-line options for patients with EGFR exon 20 insertions or KRAS G12C mutations - & the rationale in our latest podcast episode https://t.co/yIzwf6akKb (@BrittanyEHarvey)
10 months ago
Clinical • EGFR exon 20 • Metastases
|
EGFR (Epidermal growth factor receptor) • KRAS (KRAS proto-oncogene GTPase)
|
KRAS mutation • EGFR mutation • KRAS G12C • EGFR exon 20 insertion • KRAS G12 • EGFR exon 20 mutation
10ms
Cemiplimab is an immunotherapy drug used to treat advanced non-small cell lung cancer (NSCLC). ROS1 fusion is a genetic variant in NSCLC, while EGFR mutation and ALK fusion are two other common NSCLC genetic variants. (@forista8)
10 months ago
IO biomarker • Metastases
|
EGFR (Epidermal growth factor receptor) • ALK (Anaplastic lymphoma kinase) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS)
|
EGFR mutation • ALK fusion • ROS1 fusion
|
Libtayo (cemiplimab-rwlc)
10ms
1. First in man study of gleevec in CML. 2. Discovery of EGFR mutations in patients who respond to gefitinib. 3. Whole genome sequencing of the first AML genome. (@rosslevinemd)
10 months ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
gefitinib • imatinib
10ms
WATCH: Benjamin Besse, MD, PhD, discuss the biomarker analysis of the phase 1/1b CHRYSALIS-2 study of amivantamab & lazertinib in EGFR-mutated #NSCLC. #lcsm | @BenjaminBesseMD @GustaveRoussy https://t.co/HefAm5R0C8 (@TargetedOnc)
10 months ago
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Rybrevant (amivantamab-vmjw) • Leclaza (lazertinib)
10ms
New in #JIPO "Optimizing the Treatment for Advanced Non–Small-Cell Lung Cancer with Mutated Epidermal Growth Factor Receptor in Low-Income Countries, A Review" by Drs Alali and Saifo https://t.co/DOQ79Op0Bj #lungcancer @MousaMAlali @ANaingMD @weoncologists @OncologyNetwork (@JIPOEditors)
10 months ago
Review • Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
10ms
Case report of a patient with #EGFR mutant NSCLC who developed an acquired #BRAF V600E mutation on osimertinib as well as leptomeningeal disease and achieved durable control with osimertinib, dabrafenib, and trametinib. #JTOCRR @JTOonline https://t.co/TcycKvLI9x (@StephenVLiu)
10 months ago
Clinical
|
EGFR (Epidermal growth factor receptor) • BRAF (B-raf proto-oncogene)
|
BRAF V600E • EGFR mutation • BRAF V600
|
Mekinist (trametinib) • Tagrisso (osimertinib) • Tafinlar (dabrafenib)
10ms
Befotertinib another third gneration agent in EGFR mutated NSCLC @Bhosale26Bharat @AshayKarpe59998 @Nandinimenon18 https://t.co/1B3U8IKTTd (@DrVijayPatil11)
10 months ago
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Semena (befotertinib)
10ms
First line treatment patterns for patients with EGFR mutant lung cancer in #LATAM #lcsm with @GlopesMd @CPupareli Dr. William William & Jeronimo Rodriguez Cid (@GRecondoMD)
10 months ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
10ms
What is the role of immunotherapy alone or in combination in patients with EGFR mutant lung cancer? Great debate in #LATAMoncologySummit @ClaudioVladmir @GlopesMd @JorgeAlatorreA1 💡 (@GRecondoMD)
10 months ago
Clinical • IO biomarker
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
10ms
The "Lazarus Response" in Treatment-Naive, Poor Performance Status Patients With Non-Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Mutation by @coreylangermd #TBT https://t.co/VddAGIsLyd (@ASCOBuzz)
10 months ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
10ms
Benjamin Besse, MD, PhD, discussed phase 1/1b CHRYSALIS-2 data of amivantamab + lazertinib in EGFR-mutated #NSCLC. #lcsm | @BenjaminBesseMD @GustaveRoussy https://t.co/zlllgfab3r (@TargetedOnc)
10 months ago
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Rybrevant (amivantamab-vmjw) • Leclaza (lazertinib)
10ms
Lazertinib vs Gefitinib as First-line Treatment in Patients with EGFR-mutated advanced NSCLC: LASER301 Lazertinib vs Gefitinib mPFS➡️20.6 vs 9.7 mo ORR➡️76% vs 76% mDOR➡️19.4 vs 8.3 mo 18-m OS➡️80% vs 72% @JCO_ASCO @OncoAlert https://t.co/62K6Lo7F2q (@dr_yakupergun)
10 months ago
Clinical • Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
gefitinib • Leclaza (lazertinib)
10ms
Excited to share our case reports detailing various therapeutic strategies for overcoming EGFR mutations as acquired resistance mechanisms in ALK NSCLC just published in @FrontOncology ⬇️⬇️ #LionelMichaux 👏 @CadranelJ https://t.co/ImlKqSNwm6 (@FalletVincent)
10 months ago
Clinical
|
EGFR (Epidermal growth factor receptor) • ALK (Anaplastic lymphoma kinase)
|
EGFR mutation
10ms
Are you ready for targeted neoadjuvant therapy for EGFR and KRAS G12C mutant NSCLC? @MNagasaka and @kamarroneMD discuss ongoing trials with these new treatment paradigms. More discussion to come later in the program! #DAVAHawaiiLung https://t.co/CSNPUHba3j (@KE_Gallaway)
10 months ago
Clinical
|
EGFR (Epidermal growth factor receptor) • KRAS (KRAS proto-oncogene GTPase)
|
KRAS mutation • EGFR mutation • KRAS G12C • KRAS G12
10ms
WATCH: Benjamin Besse, MD, PhD, discusses the main findings of the phase 1/1b CHRYSALIS-2 study in EGFR-mutated #NSCLC. @BenjaminBesseMD @GustaveRoussy https://t.co/g7owFprw5y (@TargetedOnc)
10 months ago
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
10ms
#FeatureFriday Today on #FeatureFriday, we are featuring a tweet by Dr. Tejas Patil [@TejasPatilMD] highlighting the importance of comprehensive #NGS and the limitation of PCR assays in the detection of #EGFR mutations in #NSCLC. #MedTwitter (@4baseCare)
10 months ago
Next-generation sequencing
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
10ms
#ILCC23 what to do at the time of PD from acquired resistance in oncogene-driven NSCLC? Empiric or biomarker-related decision making? Is paradigm different for EGFR-mutated vs ALK vs METex14 vs KRAS G12C? Come listen to our panel discussion @HwakeleeMD @DrRoyHerbstYale @gotoPER (@drgandara)
10 months ago
EGFR (Epidermal growth factor receptor) • KRAS (KRAS proto-oncogene GTPase) • ALK (Anaplastic lymphoma kinase)
|
KRAS mutation • EGFR mutation • KRAS G12C • KRAS G12
11ms
New in #JIPO "Optimizing the Treatment for Advanced Non–Small-Cell Lung Cancer with Mutated Epidermal Growth Factor Receptor in Low-Income Countries, A Review" by Drs Alali and Saifo https://t.co/DOQ79Op0Bj #lungcancer @MousaMAlali @ANaingMD @weoncologists @OncologyNetwork (@JIPOEditors)
11 months ago
Review • Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
11ms
At #ASCO23, @DrRoyHerbstYale presented overall survival data for adjuvant osimertinib in resected, EGFR-mutated NSCLC. Read a recap in #ILCN: https://t.co/b40STpBg2f #LCSM (@IASLC)
11 months ago
Clinical
|
EGFR (Epidermal growth factor receptor) • TPBG (Trophoblast Glycoprotein)
|
EGFR mutation
|
Tagrisso (osimertinib)
11ms
@jillfeldman4 & I just finished taping: “EGFR mutations are not all the same: the importance of biomarker testing in non-small cell lung cancer (NSCLC)—a podcast discussion between patients and oncologists” w/Drs. Sarah Goldberg and @StephenVLiu. Stay tuned @EGFRResisters! #lcsm (@ivybelkins)
11 months ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
11ms
My answer would be no. I dont think we have enough data but retrospective evidence suggests patients EGFR-mutated NSCLC do not benefit with consolidation durvalumab and experienced a high frequency of irAEs. https://t.co/Pa5skwPQe8 (@TkarawadiaMD)
11 months ago
Retrospective data
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Imfinzi (durvalumab)
11ms
What value does ctDNA have for monitoring pts with resected #EGFR NSCLC? Report @JTOonline of 278 pts with resected stage I-IIIA EGFR mutant NSCLC (2015-2017) who had longitudinal ddPCR: 24% positive pre-op (42% of IIIA): 76% of those clear after surgery. https://t.co/mrTUvA0Ar6 (@StephenVLiu)
11 months ago
Clinical • Surgery • Circulating tumor DNA
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
11ms
Abstract LBA9000: Pemetrexed and platinum +/- pembrolizumab for TKI-resistant, EGFR-mutant, metastatic nonsquamous NSCLC (KEYNOTE-789) by James CH Yang. Well-powered but "MARGINALLY" negative like CheckMate 722. No durable response even in ICI responders. #ASCO23 #LCSM (@HHorinouchi)
11 months ago
Late-breaking abstract • Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Keytruda (pembrolizumab) • pemetrexed
11ms
Overall survival analysis from the ADAURA trial of adjuvant osimertinib in patients with resected EGFR‑mutated (EGFRm) stage IB–IIIA non-small cell lung cancer (NSCLC) [2023] @DrRoyHerbstYale et al. #ASCO23 LBA3 https://t.co/XvquwuG39L #lcsm #PrecisionMedicine (@mtmdphd)
11 months ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Tagrisso (osimertinib)
11ms
From #ASCO23, Thomas John discusses the results from the ADAURA study of adjuvant osimertinib in patients with resected EGFR mutated stage IB–IIIA non-small cell lung cancer. https://t.co/hXAY1yGMnj @TommyJohn00 #NSCLC #EGFRm #LCSM (@myESMO)
11 months ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
|
Tagrisso (osimertinib)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login